Investment Bank Raises ABI's Stock Target | GenomeWeb
NEW YORK (GenomeWeb News) — Jefferies Broadview investment bank has raised the price target for Applied Biosystems’ shares to a $38 a share.
As GenomeWeb News reported yesterday, ABI said fiscal first quarter revenues increased 15 percent as profit turned to a loss.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.